期刊文献+

AFP-IgM复合物在肝癌中的表达与临床关系 被引量:2

Expression of AFP-IgM immune complexes in hepatocellular carcinoma and its clinical significance
原文传递
导出
摘要 目的 分析甲胎蛋白-IgM免疫复合物(AFP—IgM)在肝细胞癌(HCC)中的含量,探讨AFP-IgM对诊断肝癌的临床意义。方法采用酶联免疫吸附法与电化学发光法,对103名正常人、74例肝癌、43例肝硬化和58例脂肪肝病人血清AFP—IgM与甲胎蛋白(AFP)含量检测,并分析其与临床病理特点之间的关系。结果应用ROC曲线确定AFP-kM和AFP的最佳切割值分别为300Au/ml和10μg/L作为诊断学意义的临界值。在此切割值下,肝癌组AFP-IgM和AFP血清水平均高于脂肪肝组和健康体检组(P〈0.05)。对早期(Ⅰ与Ⅱ期)肝癌诊断时,AFP-IgM的ROC曲线下面积大于AFP(0.91vs0.82);当肿瘤直径≤3cm时,AFP-IgM为(1090.4±571.8)Au/ml,而当直径〉3cm时,AFP-IgM为(604.9±749.9)Au/ml,两者比较P〈0.05。且AFP-IgM在诊断小肝癌时ROC曲线下面积大于AFP(0.92VS0.78);AFP-IgM对性别、年龄、乙型肝炎表面抗原、肿瘤数量、包膜的相关性无统计学意义(P〉0.05),而与肿块大小和分期密切相关。结论AFP-IgM对早期(Ⅰ与Ⅱ期)肝癌和小肝癌(≤3cm)诊断具有重要作用,且对判断肝癌的肿瘤大小与分期等具有一定的临床意义。 Objective To determine the contents of the new tumor marker alpha fetoprotein immunoglobulin M immunoeomplex (AFP-IgM) in hepatocellular carcinoma (HCC) and evaluate the correlation between the level of AFP-IgM and clinical feature of HCC. Methods The contents of AFP-IgM and AFP in serum of 103 healthy subjects, 74 patients with HCC, 43 patients with hepatic cirrhosis and 58 patients with adiposis hepatica were detected by enzyme linked immunosorbent assay and electrochemiluminescence. Results As the critical value of diagnostic significance, the best cutoff value of AFP-IgM and AFP was 300 Au/ml and 10 ug/L, respectively. Under the cutoff value, the mean serum concentrations of AFP-IgM and AFP were significantly higher in the HCC group than in the adiposis hepatica and health examination groups (P〈0.05). However, for early diagnosis of liver cancer (stage Ⅰ and Ⅱ ), the area under ROC curve of AFP-IgM was larger than that of AFP (0.91 vs 0. 82). The differences of AFP-IgM and AFP for early diagnosis of liver cancer were statistically significant. When the tumor was less than and over 3cm in diameter, the contents of AFP-IgM was (1090.4±571.8) Au/ml, and (604.9±749.9) Au/ml, respectilvely (P〈 0.05). Furthermore, the area under ROC curve of AFP-IgM was larger than that of AFP (0.92 vs 0. 78) in diagnosis of small hepatocellular carcinoma. The dependability between the level of AFP-IgM and sex, age, HBsAg, the quantity of the tumor and capsule was not significant (P〉0.05), but the level of AFP-IgM was closely correlated to the tumor size and stages. Conclusion AFP-IgM is of great significance for early diagnosis of liver cancer. Meanwhile, AFP-IgM has an effect in clinical judgment of the tumor size, differentiation and so on in liver cancer.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2009年第8期578-581,共4页 Chinese Journal of Hepatobiliary Surgery
基金 基金项目:本课题受苏州大学医学发展基金(EE12407),常州市卫生局重大招标(ZD200710)和常州市社会发展计划(CS2007202)资助
关键词 肝细胞 肿瘤标志物 甲胎蛋白-免疫球蛋白M复合物(AFP—IgM) 甲胎蛋白(AFP) Carcinoma,hepatocellular AFP-IgM immune complexes AFP
  • 相关文献

参考文献8

  • 1Shi J,Zhu L,Liu S,et al. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer, 2005,92 : 607-612.
  • 2冯众一,付维利,杨玉龙,谭文翔.原发性肝癌血源性微转移检测及临床意义的研究[J].中华肝胆外科杂志,2007,13(10):660-662. 被引量:3
  • 3Beneduce L, Castaldi F, Marino M, et al. Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes. Int J Biol Markers, 2004,19 : 155-159.
  • 4Sobin LH, Wittekind C. TNM classification of malignant tumours. (6th ed). New York: Wiley-Liss, 2002: 81.
  • 5Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology, 1983,148 : 839-843.
  • 6Jiang J,Nilsson Ehle P,Xu N. Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis, 2006,5 ; 4.
  • 7张宁,窦科峰,李韧,樊菁,张福琴.甲胎蛋白在肝癌细胞系HepG2不同亚群中的差异表达分析[J].中华肝胆外科杂志,2007,13(10):713-714. 被引量:2
  • 8Weimann A, Varnholt H, Schlitt H J, et al. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg, 2000,87 : 1182- 1187.

二级参考文献19

  • 1辛永宁,宣世英,史光军,陈桦,孙樱,张健.肝癌病人甲胎蛋白水平与T细胞亚群及NK活性的相关性研究[J].中华肝胆外科杂志,2005,11(12):851-852. 被引量:4
  • 2Mutsuko M, Naoshi N. Postoperative detection of a-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma. J Gastroenterol Hepatol, 2001,16:445-451
  • 3Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer, 1997,33 : 787-791.
  • 4Padungsutt P, Thirapagawong C, Senapad S, et al. Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy. Anticancer Res,2000,20 : 1291-1296.
  • 5Senapad S, Neungton S, Thirapakwong C, et al. Predictive value of the combined serum CA-125 and TPS during chemotherapy and before second-look laparotomy ia epithelial ovarian cancer. Anticancer Res, 2000,20: 1297-1302.
  • 6Goodell MA, Brose K, Paradis G, et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. Exp Med, 1996,183 : 1979.
  • 7Guo Y, Folio M, Geiger K, et al. Side population cells from different precursor compartments. Hematother Stem Cell Res,2003,12:71-82.
  • 8Preffer FI, Dombkowski D, Sykes M, et al. Lineage-negative side population cells with restricted hematopoietic capacity circulate in normal human adult blood:immunophenotypic and functional characterization. Stem cells, 2002,20 : 417-427.
  • 9Chiba T, Kita K, Zheng YW, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell like properties. Hepatology, 2006,44 : 240-251.
  • 10Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 2003,100 : 3983-3988.

共引文献3

同被引文献11

  • 1Jingting J, Changping W, Ning X,et al. Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma[J]. J Clin Lab Anal,2009,23(4):213-218.
  • 2乐杰主编.妇产科学[M].第5版.北京:人民卫生出版社,2002.139.
  • 3Kudo M. Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan. Liver Cancer, 2015, 4(1):39-50.
  • 4Chao DT, Lim JK, Ayoub WS, et al. Systematic review with recta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase _< 40 IU/L and significant hepatic fibrosis. Aliment Pharmacol Ther, 2014, 39(4):349-358.
  • 5Draskovic I, Londono-Vallejo A. Telomere recombination and the ALT pathway: a therapeutic perspective for cancer. Curt Pharm Des, 2014, 20(41):6466-6471.
  • 6Sreeram M, Suryakar AN, Dani NH. Is gamma-glutamyl transpeptidase a biomarker for oxidative stress in periodontitis? J Indian Soc Periodontol, 2015, 19(2): 150-154.
  • 7Staudigl C, Concin N, Grimm C, et al. Prognostic relevance of pretherapeutie gamma-g|utamyltransferase in patients with primary metastatic breast cancer. PLoS One, 2015, 10(4):e0125317.
  • 8Jin Y, Yuan MQ, Chen JQ, et al. Serum alkaline phosphatase predicts survival outcomes in patients with skeletal metastatic nasopharyngeal carcinoma. Clinics (Sao Paulo), 2015, 70(4):264-272.
  • 9D'Cruz AM, Pathiyil V. Histopathological differentiation of oral squamous cell carcinoma and salivary lactate dehydrogenase: A biochemical study. South Asian J Cancer, 2015, 4(2):58-60.
  • 10蒋敬庭,吴昌平,吴骏,秦锡虎,孙达成,季枚,徐斌,邓海峰,陆明洋,周国平,李敏,郑晓,刘检,石亮荣,Ning Xu,Peter Nilsson-Ehle.血清AFP—IgM复合物对原发性肝癌的诊断意义[J].中华检验医学杂志,2008,31(7):789-792. 被引量:9

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部